Boris Cvek
Impact in
- Oncology top 10%
- Metal complexes synthesis and properties
- Peptidase Inhibition and Analysis
- Inorganic Chemistry top 10%
- Crystal structures of chemical compounds
Papers in
-
- Ubiquitin and proteasome pathways 6
-
- Organometallic Compounds Synthesis and Characterization 6
- Co-authors
- Zdeněk Dvořák (4 shared papers)Q. Ping Dou (2 shared papers)Jan Taraba (2 shared papers)Zdeněk Škrott (2 shared papers)Vesna Milacic (1 shared paper)Joseph O. Nwankwo (1 shared paper)Pershang Farshi (1 shared paper)Rahul Deshmukh (1 shared paper)
- Journals
- Drug Discovery Today (3 papers)Current Pharmaceutical Design (2 papers)Journal of Medicinal Chemistry (1 paper)Critical Reviews in Oncology/Hematology (1 paper)Journal of Applied Biomedicine (1 paper)
- Partner nations
- CzechiaUnited StatesPortugal
In The Last Decade
Boris Cvek
22 papers receiving 844 citations
Peers
Comparison fields: 5 of 88
- Oncology 296
- Inorganic Chemistry 107
- Organic Chemistry 216
- Cancer Research 79
- Cell Biology 81
Countries citing papers authored by Boris Cvek
This map shows the geographic impact of Boris Cvek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Cvek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Cvek more than expected).
Fields of papers citing papers by Boris Cvek
This network shows the impact of papers produced by Boris Cvek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Cvek. The network helps show where Boris Cvek may publish in the future.
Co-authors
The 20 scholars most cited alongside Boris Cvek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 184 | |
| 2 | 2007 | 117 | |
| 3 | 2015 | 99 | |
| 4 | 2011 | 90 | |
| 5 | 2012 | 74 | |
| 6 | 2011 | 63 | |
| 7 | 2008 | 60 | |
| 8 | 2011 | 42 | |
| 9 | 2012 | 29 | |
| 10 | 2014 | 21 | |
| 11 | 2014 | 18 | |
| 12 | 2023 | 13 | |
| 13 | 2006 | 13 | |
| 14 | 2003 | 9 | |
| 15 | 2009 | 6 | |
| 16 | 2012 | 5 | |
| 17 | Nickel(II) dithiocarbamates with AsI3 and SbI3 as mixed ligands | 2005 | 3 |
| 18 | Nickel(II) Dithiocarbamates with Bis(2-diphenylphosphinoethyl)phenylphosphine | 2004 | 3 |
| 19 | 2022 | 3 | |
| 20 | 2010 | 3 |
About Boris Cvek
Boris Cvek is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 22 papers that have together received 859 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Organometallic Compounds Synthesis and Characterization (6 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Multiple Myeloma Research and Treatments (3 papers), Alcohol Consumption and Health Effects (3 papers), Metal complexes synthesis and properties (3 papers), Cancer, Lipids, and Metabolism (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Oncology (296 citations), Inorganic Chemistry (107 citations), Organic Chemistry (216 citations), Cancer Research (79 citations) and Cell Biology (81 citations). Boris Cvek has collaborated with scholars based in Czechia, United States and Portugal. Frequent co-authors include Zdeněk Dvořák, Q. Ping Dou, Jan Taraba, Zdeněk Škrott, Vesna Milacic, Joseph O. Nwankwo, Pershang Farshi, Rahul Deshmukh, Jinbao Liu and Richard Pastorek. Their work appears in journals such as Drug Discovery Today, Current Pharmaceutical Design, Journal of Medicinal Chemistry, Critical Reviews in Oncology/Hematology and Journal of Applied Biomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.